share_log

Surrozen Publishes Study In 'ELife' Highlihgitng Potential To Enhance Wnt-Signal Activation In Targeted SWEETS Bispecific Antibodies

Benzinga ·  Jun 12 20:32

Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment approaches

Surrozen's current SWEETS bispecific antibodies are unique TPD technologies

Results demonstrated that the two new ASGR-targeted SWEETS bispecific antibodies enhanced Wnt-signal activation through the unique TPD platform

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment